Skip to main content
SpringerLink
Log in

Expression and clinical significance of NET-1 and PCNA in hepatocellular carcinoma

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Objective Objective of this study was to detect the expression of neuroepithelial transforming gene-1 (NET-1) and proliferating cell nuclear antigen (PCNA) in hepatocellular carcinoma (HCC) and adjacent tissues, and to investigate the relation of the expression of NET-1 in HCC tissue with cancer proliferation, metastasis and clinic stages. Methods The expression of NET-1 mRNA was detected by reverse transcription-polymerase chain reaction method in 34 human HCC tissues, and it was matched with 34 paracarcinoma tissues. The expression of PCNA in HCC was analyzed by immunohistochemistry. Meanwhile, the relation of the expression with clinic pathological features of HCC was evaluated, and the correlation between the expression of NET-1 and PCNA in HCC was investigated. Results Expression of NET-1 was significantly higher in HCC than that in matched paracarcinoma tissues. The expression of NET-1 was significantly higher in TMN III–IV HCC tissues when compared with TMN I–II HCC tissues (P < 0.05). The expression level of NET-1 in HCC tissues was related to intrahepatic metastasis and portal vein infiltration. The expression of NET-1 in HCC tissues was positively correlated with PCNA. Conclusions The expression of NET-1 may relate to proliferation, metastasis and clinic stages of HCC. The expression of NET-1 in HCC tissues may positively correlate to the TMN stages.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology 2004;127:S87–S96.

    Article  PubMed  CAS  Google Scholar 

  2. Symons M, Rusk N. Control of vesicular trafficking by Rho GTPases. Curr Biol 2003;13:409–18.

    Article  Google Scholar 

  3. Alberts AS, Treisman R. Activation of RhoA and SAPK/JNK signalling pathways by the RhoA-specific exchange factor mNET1. EMBO J 1998;17:4075–85.

    Article  PubMed  CAS  Google Scholar 

  4. Wollscheid V, Kuhne-Heid R, Stein I, et al. Identification of a new proliferation-associated protein net-1/c4-8 characteristic for a subset of high-grade cervical intraepithelial neoplasia and cervical carcinoma. Int J Cancer 2002;99(6):771–5.

    Article  PubMed  CAS  Google Scholar 

  5. Leyden J, Murray D, Moss A, et al. NET-1 and Myeov: computationally identified mediators of gastric cancer. Br J Cancer 2006;94(8):1204–12.

    Article  PubMed  CAS  Google Scholar 

  6. Lupberger J, Hildt E. Hepatitis B virus-induced oncogenesis. World J Gastroenterol 2007;13(1):74–81.

    PubMed  CAS  Google Scholar 

  7. Gobel T, Vorderwulbecke S, Hauck K, Fey H, Haussinger D, Erhardt A. New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples. World J Gastroenterol 2006;12(47):7604–12.

    PubMed  Google Scholar 

  8. Minagawa M, Makuuchi M. Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus. World J Gastroenterol 2006;12(47):7561–7.

    PubMed  CAS  Google Scholar 

  9. Park Y, Chae KJ, Kim YB, et al. Apoptosis and proliferation in hepatocarcinogenesis related to cirrhoisis. Cancer 2001;92(11):2733–8.

    Article  PubMed  CAS  Google Scholar 

  10. Pizem J, Marolt VF, Luzar B, et al. Proliferative and apoptotic activity in hepatocellular carcinoma and surrounding non-neoplastic liver tissue. Pflugers Arch 2001;442(6 Suppl 1):174–6.

    Article  Google Scholar 

  11. Zeng WJ, Liu GY, Xu J, Zhou XD, Zhang YE, Zhang N. Pathological characteristics, PCNA labeling index and DNA index in prognostic eveluation of patients with oderately differentiated hepatocellular carcinoma. World J Gastroenterol 2002;8:1040–4.

    PubMed  CAS  Google Scholar 

  12. Kong XB, Liang LJ, Huang JF. A Study of correlation between apoptosis,expression of p21 protein and PCNA and the clinical prognosis in hepatocellular carcinoma. Aizheng J 1999;18:426–9.

    Google Scholar 

  13. Shen LJ, Zhang HX, Zhang ZJ, et al. Detection of HBV, PCNA and GST-pi in hepatocelluar carcinoma and chronic liver diseases. World J Gastroenterol 2003;9(3):459–62.

    PubMed  CAS  Google Scholar 

  14. Rossman KL, Der CJ, Sondek J. GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 2005;6:167–80.

    Article  PubMed  CAS  Google Scholar 

  15. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature 2002;420:629–35.

    Article  PubMed  CAS  Google Scholar 

  16. Jaffe AB, Hall A. Rho GTPases in transformation and metastasis. Adv Cancer Res 2002;84:57–80.

    Article  PubMed  CAS  Google Scholar 

  17. Sahai E, Marshall CJ. RHO-GTPases and cancer. Nat Rev Cancer 2002;2:133–42.

    Article  PubMed  Google Scholar 

  18. Yauch RL, Hemler ME. Specific interactions among transmembrane 4 superfamily (TM4SF) proteins and phosphoinositide 4-kinase. Biochem J 2000;351:629–37.

    Article  PubMed  CAS  Google Scholar 

  19. Serru V, Dessen P, Boucheix C, Rubinstein E. Sequence and expression of seven new tetraspans. Biochim Biophys Acta 2000;1478:159–63.

    PubMed  CAS  Google Scholar 

  20. Maecker HT, Todd SC, Levy S. The tetraspanin superfamily: molecular facilitators. FASEB J 1997;11(6):428–42.

    PubMed  CAS  Google Scholar 

  21. Serru V, Le Naour F, Billard M, et al. Selective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/alpha3beta1, CD151/alpha6beta1) under conditions disrupting tetraspan interactions. Biochem J 1999;340:103–11.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We appreciate the contributions of Mr. Hong Xia and Ms. Li Yu for their technical support during the experiment at the Research Institute of Gastroenterology & Hepatology of Renmin Hospital of Wuhan University.

Author information

Authors and Affiliations

  1. Department of General Surgery, Renmin Hospital of Wuhan University, 430060, Wuhan, Hubei Province, China

    Shi-Qiang Shen, Kun Li & Neng Zhu

  2. Department of Surgery II, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan

    Akimasa Nakao

Authors
  1. Shi-Qiang Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kun Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Neng Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Akimasa Nakao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shi-Qiang Shen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shen, SQ., Li, K., Zhu, N. et al. Expression and clinical significance of NET-1 and PCNA in hepatocellular carcinoma. Med Oncol 25, 341–345 (2008). https://doi.org/10.1007/s12032-008-9042-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-008-9042-6

Keywords

Search

Navigation